Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keefer

Showing results (1001-1010 of 1,129) with videos related to

Pageof 113
Sort By:
Journal of the American Chemical Society|October 13, 2005
Diazeniumdiolate ions as leaving groups in anomeric displacement reactions: a protection-deprotection strategy for ionic diazeniumdiolatesBrett M Showalter, Melissa M Reynolds, Carlos A Valdez, et al.
Journal of Medicinal Chemistry|June 7, 2008
Hydrolytic reactivity trends among potential prodrugs of the O2-glycosylated diazeniumdiolate family. Targeting nitric oxide to macrophages for antileishmanial activityCarlos A Valdez, Joseph E Saavedra, Brett M Showalter, et al.
Developmental Medicine and Child Neurology|February 12, 2011
Identification of a core set of exercise tests for children and adolescents with cerebral palsy: a Delphi survey of researchers and cliniciansOlaf Verschuren, Marjolijn Ketelaar, Daniel Keefer, et al.
AIDS Research and Human Retroviruses|May 20, 1996
Safety and immunogenicity of Env 2-3, a human immunodeficiency virus type 1 candidate vaccine, in combination with a novel adjuvant, MTP-PE/MF59. NIAID AIDS Vaccine Evaluation GroupM C Keefer, B S Graham, M J McElrath, et al.
Journal of the National Cancer Institute|January 11, 2012
Estrogen metabolism and risk of breast cancer in postmenopausal womenBarbara J Fuhrman, Catherine Schairer, Mitchell H Gail, et al.
The Journal of Infectious Diseases|February 1, 1996
A dose-ranging study of a prototype synthetic HIV-1MN V3 branched peptide vaccine. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation GroupG J Gorse, M C Keefer, R B Belshe, et al.
Endoscopy International Open|May 27, 2016
A randomized controlled cross-over trial and cost analysis comparing endoscopic ultrasound fine needle aspiration and fine needle biopsyA Aziz Aadam, Sachin Wani, Ashley Amick, et al.
Biochemical Pharmacology|December 24, 2014
The liver-selective NO donor, V-PYRRO/NO, protects against liver steatosis and improves postprandial glucose tolerance in mice fed high fat dietEdyta Maslak, Piotr Zabielski, Kamila Kochan, et al.
Plos Pathogens|November 29, 2021
Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trialsStephanie Fischinger, Deniz Cizmeci, Davy Deng, et al.
Plos One|April 25, 2012
9G4 autoreactivity is increased in HIV-infected patients and correlates with HIV broadly neutralizing serum activityJames J Kobie, Danielle C Alcena, Bo Zheng, et al.
Pageof 113

Showing results (1001-1010 of 1,129) with videos related to

Sort By:
Pageof 113
Journal of the American Chemical Society|October 13, 2005
Diazeniumdiolate ions as leaving groups in anomeric displacement reactions: a protection-deprotection strategy for ionic diazeniumdiolatesBrett M Showalter, Melissa M Reynolds, Carlos A Valdez, et al.
Journal of Medicinal Chemistry|June 7, 2008
Hydrolytic reactivity trends among potential prodrugs of the O2-glycosylated diazeniumdiolate family. Targeting nitric oxide to macrophages for antileishmanial activityCarlos A Valdez, Joseph E Saavedra, Brett M Showalter, et al.
Developmental Medicine and Child Neurology|February 12, 2011
Identification of a core set of exercise tests for children and adolescents with cerebral palsy: a Delphi survey of researchers and cliniciansOlaf Verschuren, Marjolijn Ketelaar, Daniel Keefer, et al.
AIDS Research and Human Retroviruses|May 20, 1996
Safety and immunogenicity of Env 2-3, a human immunodeficiency virus type 1 candidate vaccine, in combination with a novel adjuvant, MTP-PE/MF59. NIAID AIDS Vaccine Evaluation GroupM C Keefer, B S Graham, M J McElrath, et al.
Journal of the National Cancer Institute|January 11, 2012
Estrogen metabolism and risk of breast cancer in postmenopausal womenBarbara J Fuhrman, Catherine Schairer, Mitchell H Gail, et al.
The Journal of Infectious Diseases|February 1, 1996
A dose-ranging study of a prototype synthetic HIV-1MN V3 branched peptide vaccine. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation GroupG J Gorse, M C Keefer, R B Belshe, et al.
Endoscopy International Open|May 27, 2016
A randomized controlled cross-over trial and cost analysis comparing endoscopic ultrasound fine needle aspiration and fine needle biopsyA Aziz Aadam, Sachin Wani, Ashley Amick, et al.
Biochemical Pharmacology|December 24, 2014
The liver-selective NO donor, V-PYRRO/NO, protects against liver steatosis and improves postprandial glucose tolerance in mice fed high fat dietEdyta Maslak, Piotr Zabielski, Kamila Kochan, et al.
Plos Pathogens|November 29, 2021
Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trialsStephanie Fischinger, Deniz Cizmeci, Davy Deng, et al.
Plos One|April 25, 2012
9G4 autoreactivity is increased in HIV-infected patients and correlates with HIV broadly neutralizing serum activityJames J Kobie, Danielle C Alcena, Bo Zheng, et al.
Pageof 113